Press Releases
AppLovin Corporation, (NASDAQ: APP) (“AppLovin” or the “Company”) the leading marketing platform, today announced it will report financial results for the fourth quarter and fiscal year 2025 on Wednesday, February 11, 2026 after the U.S. stock market closes.
By AppLovin Corp. · Via Business Wire · January 7, 2026
Rocky Brands, Inc. (NASDAQ: RCKY) today announced that the management team is participating in the 2026 ICR Conference. A fireside chat presentation is scheduled for Monday, January 12, 2026, at 2:30 p.m. Eastern Time. The presentation will be simultaneously broadcast on the internet and will be available at https://investors.rockybrands.com.
By Rocky Brands, Inc. · Via Business Wire · January 7, 2026
DoorDash, Inc. (NASDAQ: DASH) today announced that the company’s fourth quarter and full year 2025 financial results will be released after the U.S. financial markets close on Wednesday, February 18, 2026. The company’s earnings press release will be made available on the DoorDash Investor Relations website at ir.doordash.com.
By DoorDash · Via Business Wire · January 7, 2026
Via PRLog · January 7, 2026
New York, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Twelve Seas Investment Company III (Nasdaq: TWLVU) (the “Company”) announced today that, commencing January 9, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and rights included in the units. The Class A ordinary shares and rights that are separated will trade on the Nasdaq Global Market under the symbols “TWLV” and “TWLVR,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “TWLVU.”
By Twelve Seas Investment Company III · Via GlobeNewswire · January 7, 2026
Abivax Provides 2026 Corporate Outlook
By Abivax · Via GlobeNewswire · January 7, 2026
Mr. Dewhurst Brings Over 30 Years of Life Sciences and M&A Experience to the Board, Aligning with the Company’s Strategic Long-Term Goals for Growth and Expansion
By Turn Therapeutics · Via GlobeNewswire · January 7, 2026
Five9, Inc. (NASDAQ:FIVN), provider of the Intelligent CX Platform, today announced that members of its management team will present at the following investor conference:
By Five9, Inc. · Via Business Wire · January 7, 2026
CARDINAL Phase 1/2 trial of TERN-701 enrolling well, with multiple important milestones in 2026
By Terns Pharmaceuticals, Inc. · Via GlobeNewswire · January 7, 2026
WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, announced that Aaron Saak, President and Chief Executive Officer, and Christina Cristiano, Senior Vice President and Chief Financial Officer, will participate in a fireside chat at the CJS Securities 26th Annual New Ideas for the New Year Conference on Wednesday, January 14, 2026 at 8:45 a.m. ET.
By Crane NXT · Via GlobeNewswire · January 7, 2026
CHARLOTTE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Terrestrial Energy Inc. (NASDAQ: IMSR) (“Terrestrial Energy” or “the Company”), a developer of small modular nuclear power plants using its Generation IV reactor technology, announced today that it will participate in the 28th Annual Needham Growth Conference on Tuesday, January 13, 2026, in New York, NY.
By Terrestrial Energy Inc. · Via GlobeNewswire · January 7, 2026
FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that it intends to offer and sell, subject to market and other conditions, shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock, in an underwritten public offering. In addition, Phathom intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the total number of the securities offered in the public offering. There can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the offering.
By Phathom Pharmaceuticals · Via GlobeNewswire · January 7, 2026
BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 11:15 a.m. PST.
By Annexon Biosciences · Via GlobeNewswire · January 7, 2026
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 44thAnnual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific Time.
By RAPT Therapeutics, Inc. · Via GlobeNewswire · January 7, 2026
NOVATO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's chief executive officer and president, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT.
By Ultragenyx Pharmaceutical Inc. · Via GlobeNewswire · January 7, 2026
FRAMINGHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Chief Financial Officer, Casey Heller, will present at the 28th Annual Needham Growth Conference.
By Definitive Healthcare Corp. · Via GlobeNewswire · January 7, 2026
ROCHESTER, N.Y., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its third quarter fiscal 2026 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Chief Financial Officer, Garth Hankinson, on Thursday, January 8, 2026 at 10:30 a.m. ET. Visit ir.cbrands.com to locate information for joining the conference call, or a live, listen-only webcast of the conference call.
By Constellation Brands, Inc. · Via GlobeNewswire · January 7, 2026
The Harbin International Ice and Snow Economy Expo 2026 opened on January 6 in Harbin, capital of northeast China’s Heilongjiang Province, showcasing cutting-edge achievements of the ice-and-snow industry.
Via Get News · January 7, 2026
Zehl & Associates, the nationally acclaimed personal injury and wrongful death law firm, has been recognized for securing a record-setting $37.5 million wrongful death verdict against Oncor Electric Delivery Company following a deadly crash in Dallas. TopVerdict.com named the case one of the Top 50 Wrongful Death Verdicts in the United States for 2024.
By Zehl & Associates PC · Via Business Wire · January 7, 2026
Via PRLog · January 7, 2026
NEW YORK - Panxo has launched the public version of its AI traffic monetization platform, purpose-built to help publishers monetize visitors referred by conversational AI assistants. The company says it is the first infrastructure platform designed specifically to turn conversational AI referrals into measurable revenue for publishers.
Via Get News · January 7, 2026
Coastal States Bank (“CSB”) marked a significant milestone, ringing the Opening Bell at the New York Stock Exchange (NYSE) in celebration of the initial public offering (IPO) and official listing of its holding company, CoastalSouth Bancshares, Inc. (NYSE: COSO). The opening bell was rung by the company’s Chairman, Jim MacLeod and President and Chief Executive Officer, Stephen R. Stone, who were joined on the podium by members of the bank’s board of directors and senior leadership team.
By CoastalSouth Bancshares · Via Business Wire · January 7, 2026
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 14, 2026 at 11:15 a.m. PT.
By Mirum Pharmaceuticals, Inc. · Via Business Wire · January 7, 2026
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 45th annual J.P. Morgan Healthcare Conference in San Francisco. Senior leadership will present on behalf of the Company on Monday, January 12th, 2026 at 9:00 AM Pacific Standard Time.
By Bruker Corporation · Via Business Wire · January 7, 2026
FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced certain preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025.Preliminary Fourth Quarter 2025 Financial Results
By Phathom Pharmaceuticals · Via GlobeNewswire · January 7, 2026
WESTLAKE VILLAGE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced that it has commenced a proposed underwritten public offering of its common stock. In addition, Genelux expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the number of shares of common stock sold in connection with the proposed offering. All shares are being offered by Genelux. The proposed offering is subject to market and other customary closing conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the proposed offering.
By Genelux Corporation · Via GlobeNewswire · January 7, 2026
BOSTON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that it has commenced an underwritten public offering of $200.0 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of common stock. All of the shares of common stock and pre-funded warrants to purchase shares of common stock in the proposed offering are to be sold by Monte Rosa. Monte Rosa also intends to grant the underwriters a 30-day option to purchase up to an additional $30.0 million of shares of its common stock. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
By Monte Rosa Therapeutics, Inc. · Via GlobeNewswire · January 7, 2026
Preventogen™ eradicated Candida auris antibiotic-resistant strain by 99.99% at 30, 90 and 120 seconds with a formidable 5.61 log reduction.
Via ACCESS Newswire · January 7, 2026
First Business Financial Services, Inc. (the “Company” or “First Business Bank”) (Nasdaq:FBIZ) invites participation in a conference call to discuss the Company’s financial and operating performance during its fourth quarter ended December 31, 2025. The conference call and webcast may contain forward-looking statements and other material information.
By First Business Financial Services, Inc. · Via Business Wire · January 7, 2026
Tetra Tech, Inc. (NASDAQ: TTEK), a leading provider of high-end consulting and engineering services in water, environment, and sustainable infrastructure, announced today the planned dates for its first quarter 2026 results and conference call.
By Tetra Tech, Inc. · Via Business Wire · January 7, 2026
Singapore, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Republic Power Group Limited (“RPGL” or the “Company”), (NASDAQ: RPGL) announced today that on January 5, 2026, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”), notifying the Company that the minimum bid price per share for its Class A ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2).
By Republic Power Group Limited · Via GlobeNewswire · January 7, 2026
PHILADELPHIA, PA, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Art Technology Acquisition Corp. (NASDAQ:ARTCU) (the “Company”) today announced the closing of its initial public offering of 22,000,000 units. The offering was priced at $10.00 per unit, resulting in gross proceeds to the Company of $220,000,000. The Company has granted the underwriter a 45-day option to purchase up to an additional 3,300,000 units at the initial public offering price to cover over-allotments, if any.
By Art Technology Acquisition Corp. · Via GlobeNewswire · January 7, 2026
DENVER, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pure Cycle Corporation (NASDAQ Capital Market: PCYO) (“Pure Cycle”, “we”, “us” or “our”) announced its financial results for the three months ended November 30, 2025. Pure Cycle reported $4.5 million of net income for the three months ended November 30, 2025, which is a 16% increase in net income from the same period in 2024 and marks the twenty-sixth consecutive fiscal quarter with positive net income. Pure Cycle reported $0.19 of earnings per fully diluted common share, which is up from $0.16 in the same period in 2024, a 19% increase. Pure Cycle continues to see demand for entry level lots at our Sky Ranch Master Planned Community despite national headwinds in homebuilding. By partnering with our national home builders, we deliver finished lots on an annual cadence that allows for steady absorption while navigating cyclical housing industry trends.
By Pure Cycle Corporation · Via GlobeNewswire · January 7, 2026
- Reported 12-month overall survival (OS) in Phase 2a clinical trial nearly double the benchmark from pivotal study of standard of care gemcitabine/nab-paclitaxel (GnP) -
By Immuneering Corporation · Via GlobeNewswire · January 7, 2026
AMF Regulated InformationChâtillon, France, January 7, 2026
By DBV Technologies S.A. · Via GlobeNewswire · January 7, 2026
PHILADELPHIA, PA, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Crane Harbor Acquisition Corp. II (NASDAQ:CRANU) (the “Company”) announced today that, commencing January 12, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and rights included in the units. The Class A ordinary shares and rights that are separated will trade on the Nasdaq Global Market under the symbols “CRAN” and “CRANR,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “CRANU.”
By Crane Harbor Acquisition Corp. II · Via GlobeNewswire · January 7, 2026
CHICAGO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Amlan® International, a global leader in mineral-based feed additives, will exhibit at the International Production & Processing Expo (IPPE) 2026, taking place January 27–29 at the Georgia World Congress Center in Atlanta, Georgia. Attendees are invited to visit Amlan at booth B6041 to learn how science-backed solutions can help optimize gut health, feed efficiency and profitability in antibiotic-free poultry production.
By Oil-Dri Corporation Of America · Via GlobeNewswire · January 7, 2026
Nassau, The Bahamas, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The Bahamas Ministry of Tourism, Investments & Aviation (BMOTIA) is proud to announce that its official website, Bahamas.com, has been named Caribbean’s Best Tourism Authority Website 2025 at the 5th Annual World Travel Tech Awards.
By The Bahamas Ministry of Tourism · Via GlobeNewswire · January 7, 2026
Trinity Health today announced that it delivered $2.9 billion in programs and services during fiscal year 2025, reaffirming its commitment to patients and communities despite significant pressures facing the health care industry. Investments made across Trinity Health’s 25-state footprint include covering $310 million in care costs helping nearly 450,000 patients receive necessary routine and emergency care; completing more than 1 million screenings to identify patients’ food, housing and other social needs affecting their health; and generating $1.18 billion in investments in affordable housing, food access, education and employment since 2018.
By Trinity Health · Via Business Wire · January 7, 2026
Bellingham, WA - Signature Healthcare at Home is proud to support the Bellingham community with high-quality, compassionate Home Health services designed to help individuals recover, heal, and regain independence in the comfort of their own homes. With a strong commitment to patient-centered care, Signature Healthcare at Home continues to be a trusted healthcare partner for families throughout Whatcom County.
Via Get News · January 7, 2026
KBRA assigns preliminary ratings to OHS Issuer, LLC, Series 2026-1/2 (OHS 2026-1/2 or the Series 2026-1/2 Notes), a service contract securitization that is primarily collateralized by home service contracts. OHS 2026-1/2 represents OHS Issuer, LLC’s (the Issuer) first securitization. The transaction structure is a master trust, and as such, the indenture permits the issuance of additional classes and series of notes subject to certain conditions, including rating agency confirmation. The proceeds from the Series 2026-1/2 Notes are being used to repay the Company’s existing debt, fund transaction accounts, pay transaction fees and expenses and for general corporate purposes which may include a dividend to the sponsor and to management.
By Kroll Bond Rating Agency, LLC · Via Business Wire · January 7, 2026
ShowcaseMLS is like a new, simpler Zillow, giving people a much easier way to find the home of their dreams.
Via Press Release Distribution Service · January 7, 2026
Lou Square, a reputable online vape retailer, has announced that Cuvie Black Ice disposable vapes are now in stock.
Via Press Release Distribution Service · January 7, 2026
Turkey is drawing foreign professionals with cost-effective, business-friendly cities beyond central Istanbul offering strong infrastructure and incentives
Via Press Release Distribution Service · January 7, 2026
Local red tape continues to prevent thousands of homeowners and business owners from rebuilding
By U.S. Small Business Administration · Via GlobeNewswire · January 7, 2026
Recently, the 2026 Suzhou “No. 1 Road around Taihu Lake” New Year Run was held in Wuzhong District, Suzhou, East China’s Jiangsu province. Under warm winter sunshine, 4,000 participants set off on a picturesque run along the famed No. 1 Road around Taihu Lake, bidding farewell to the old year and welcoming the new with energetic strides.
Via Get News · January 7, 2026
As the bell rings once again at the turn of the year, the world is still filled with the clamor of “starting anew.” Yet at the beginning of this new year, PINSPARK proposes a gentler but firmer idea: the new year is not about redefining yourself, but about moving forward and finding the rhythm that best suits the present.
Via Get News · January 7, 2026
Ametris (formerly ActiGraph), a global digital health solutions provider transforming real-world patient data into validated clinical evidence, today reported significant momentum with the pharmaceutical industry, including partnerships with eight of the top ten companies, as sponsors seek new ways to capture meaningful signals of disease progression and treatment effect. Ametris’ leadership team will be in San Francisco for the 44th Annual J.P. Morgan Healthcare Conference, January 12–15, 2026.
By Ametris · Via Business Wire · January 7, 2026
On January 1, 2026, Songjiang District in Shanghai organized a distinctive cultural journey themed around “climbing high for a broader view and tracing one’s roots.” Two families from Germany and Hungary—the latter being recipients of the Shanghai Magnolia Commemorative Award—took part in an immersive experience that allowed them to appreciate the charm of the Chinese New Year holiday and gain a deeper understanding of the cultural heritage known as the “Shanghai’s Root.”
Via Get News · January 7, 2026
LAS VEGAS - January 7, 2026 - On the eve of the world’s most influential tech event, CES 2026, the Korea Institute of Startup and Entrepreneurship Development (KISED) successfully hosted ‘K-Startup Night’ at the Treasure Island Hotel in Las Vegas. This premier networking event brought together approximately 200 key stakeholders, including South Korean government officials, leading entrepreneurs, global venture capitalists, and international media, to foster strategic partnerships before the official exhibition floors opened.
Via Get News · January 7, 2026